ASP Isotopes (ASPI) Stock Price

ASP Isotopes Price

NYSE·CLOSED
1.54
​
Market closed

Over the last 6 years ASP Isotopes grew revenue by 0.9% annually, reaching 23.85 M USD. For ASP Isotopes, the net margin of -734.2% is down versus -45.3% a few years ago. The consensus 12-month price target for ASP Isotopes is 4.59 USD, about 198.1% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

ASP Isotopes stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ASP Isotopes business model & stock analysis

ASP Isotopes, Inc. generates revenue through the development and commercialization of enriched isotopes using its Aerodynamic Separation Process (ASP technology). The company focuses on producing Carbon-14 (C-14), Molybdenum-100 (Mo-100), and Silicon-28 (Si-28) for specialized markets, with plans to expand into Uranium-235 (U-235) for the nuclear energy sector. Its subsidiaries, ASP Isotopes Guernsey Limited and Enriched Energy LLC, handle high-value isotope production and uranium development, respectively. The company licenses ASP technology from Klydon Proprietary Ltd for all isotope-related activities. The target customers for C-14, Mo-100, and Si-28 are highly specialized end markets requiring low-volume, high-value isotopes. Enriched Energy LLC specifically targets the nuclear energy market with uranium products. ASP Isotopes Guernsey Limited focuses on niche applications where isotope enrichment is critical, such as medical and industrial uses. The company’s revenue model relies on the sale of these enriched isotope products to specialized industries rather than mass-market consumers. ASP Isotopes, Inc. operates under a pre-commercial stage, meaning it is still developing its production capabilities and has not yet achieved full-scale commercialization. The company’s initial revenue streams will come from the sale of C-14, Mo-100, and Si-28, with future expansion into U-235 expected to diversify its product portfolio. The Aerodynamic Separation Process (ASP technology) is central to its business model, enabling the enrichment of natural isotopes into higher concentration products for specialized applications.

Frequently asked questions about ASP Isotopes

Analysts currently set an average price target of 4.59 USD for the ASP Isotopes stock (median: 4.59 USD), implying +198.1 % versus the latest price. The consensus is based on 7 analyst ratings.

9 analysts currently rate the ASP Isotopes stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect ASP Isotopes to generate revenue of 19.95 M USD and earnings per share of -0.78 USD.

Converted at the current exchange rate, the ASP Isotopes share trades at 1.40 EUR (1.54 USD).

The expected revenue of ASP Isotopes is 19.95 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of ASP Isotopes is -87.58 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of ASP Isotopes is currently -1.96. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ASP Isotopes stock.

The price-to-sales ratio (P/S) of ASP Isotopes is currently 8.62. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ASP Isotopes stock.

The Eulerpool Quality Score for ASP Isotopes is 3/10.

The ISIN of ASP Isotopes is US00218A1051. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of ASP Isotopes is ASPI. The ticker symbol is used to trade ASP Isotopes shares on the stock exchange.

Fair ValueTerminal
1.34 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Chemicals
Number of shares
Employees
Revenue per Employee
88,003.69 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Nov 10, 2022
ISIN
US00218A1051
Cusip
00218A105
Market capitalization
192.67 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-1.96
P/Ee 2027
-1.65
P/Ee 2028
2.08
P/Ee 2029
0.59
P/Ee 2030
2.91
P/S
P/Se
8.62
EV/EBIT
—
P/B Ratio
0.94
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-41.68 %
Last updated Nov 18, 2026, 4:25 AM

ASP Isotopes Peer Group

ASP Isotopes FIGI

ASPI:US · BBG013Y062J3ASPI:UA · BBG019LXM7R4ASPI:UC · BBG019LXM7S3ASPI:UN · BBG019LXM7X7ASPI:UP · BBG019LXM7Z5ASPI:UB · BBG019LXM829ASPI:UM · BBG019LXM856ASPI:UX · BBG019LXM865ASPI:UR · BBG019LXM883ASPI:UD · BBG019LXM8G4ASPI:UF · BBG019LXM8P4ASPI:VY · BBG019LXM8Q3

All fundamentals and in-depth analysis of ASP Isotopes

Our stock analysis for ASP Isotopes stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ASP Isotopes. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.